Delivery Order SPE2DR25D3103-SPE2DR26F9J93
Award Date 11/26/25
Potential Completion Date 12/18/25
Potential Value $94K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $29,807.56 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials on September 5, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by September 26, 2025, with performance based in Conshohocken, Pennsylvania. Jemperli is a specialized pharmaceutical product used in oncology treatment, reflecting the Defense Logistics Agency's Medical Supply Chain's responsibility for procuring...
- The Defense Logistics Agency awarded a $24,468.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Jemperli 500 mg/10 ml vials. This non-competitive delivery order is scheduled for completion by February 9, 2026, with fulfillment occurring at the awardee's facility in Conshohocken, Pennsylvania. Jemperli is a specialized oncology medication used in the treatment of certain hematologic malignancies, representing the type of critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $59,615.12 and firm fixed pricing. This is a competitive award with no set-aside designation, requiring completion by September 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $37,259.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of JEMPERLI 500 mg/10 mL vials. This non-set-aside competitive award was issued on August 1, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. JEMPERLI is a specialized pharmaceutical product, and this order represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $16,312.56 to AmerisourceBergen Drug Corp for 500 mg/10 mL vials of Jemperli, an oncology medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of February 10, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a $29.8K delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with a completion date of November 10, 2025, with performance conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated...
- The Defense Logistics Agency has awarded a delivery order valued at $7,451.89 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by August 11, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15.7K to supply Jemperli 500 mg/10 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of January 14, 2026. The award represents a non-competitive, non-set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that runs through December 2026. Performance...
- The Defense Logistics Agency awarded a $29,807.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jemperli 500 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Jemperli (venetoclax) 500 mg/10 mL vials. This $22,355.67 firm fixed-price delivery order carries an ultimate completion date of October 15, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...